Pancreatic Cancer Research

ResearcherOsaka International Cancer InstituteActive in the last 2 years

Hideaki Tahara

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1735-5372; OpenAlex author ID A5019908789. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
13
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Clinical significance of non-invasive in vitro drug sensitivity profiling using pancreatic cancer organoids derived from saline flushes collected during routin… Last author DOI 10.1007/s12094-025-04111-9↗
  2. Establishment of organoids using residual samples from saline flushes during endoscopic ultrasound-guided fine-needle aspiration in patients with pancreatic ca… Last author DOI 10.1055/a-1713-3404↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Kenji Ikezawa · 2 shared papers, 2022–2026 · strength 0.38
  2. Shinichiro Hasegawa · 2 shared papers, 2022–2026 · strength 0.38
  3. Ryoji Takada · 2 shared papers, 2022–2026 · strength 0.38
  4. Hisataka Ogawa · 2 shared papers, 2022–2026 · strength 0.38
  5. Yugo Kai · 2 shared papers, 2022–2026 · strength 0.38
  6. Hidenori Takahashi · 2 shared papers, 2022–2026 · strength 0.38
  7. Tomoya Ekawa · 2 shared papers, 2022–2026 · strength 0.38
  8. Shigenori Nagata · 2 shared papers, 2022–2026 · strength 0.38
  9. Kazuyoshi Ohkawa · 2 shared papers, 2022–2026 · strength 0.38
  10. Yoji Kukita · 1 shared paper, 2026 · strength 0.25
  11. Makiko Urabe · 1 shared paper, 2026 · strength 0.25
  12. Nobuyasu Fukutake · 1 shared paper, 2022 · strength 0.13
  13. Takuo Yamai · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.